Company intelligence / Profile preview

Crescent Rock Capital

Summit, New Jersey, United States

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Crescent Rock Capital is a New Jersey-based investment management firm and hedge fund manager, not an operating life sciences, biotech, pharma, or healthcare company. The firm operates a global diversified equity long/short investment strategy across multiple sectors rather than developing therapeutics, diagnostics, or medical technologies. Publicly available sources describe it as an active for-profit asset manager founded in 2018. Because its business is financial investing rather than drug development, it does not have a clinical pipeline, therapeutic programs, or healthcare modalities.

Industry: Investors

Beyond the preview

Go deeper on Crescent Rock Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crescent Rock Capital.

Explore the full profile